EXELIXIS, INC. EXEL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-04-11
EXELIXIS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| WYSZOMIERSKI JACK L | director | 2026-06-01 | Sell | 3,925 | $50.55 |
| Eckhardt Sue Gail | director | 2026-06-01 | Sell | 9,812 | $50.14 |
| PAPADOPOULOS STELIOS | director | 2026-05-27 | Grant | 8,367 | — |
| Heyman Tomas J. | director | 2026-05-27 | Grant | 8,367 | — |
| Eckhardt Sue Gail | director | 2026-05-27 | Grant | 8,367 | — |
| Smith Julie | director | 2026-05-27 | Grant | 8,367 | — |
| Freire Maria C | director | 2026-05-27 | Grant | 8,367 | — |
| Beckerle Mary C | director | 2026-05-27 | Grant | 8,367 | — |
Source: SEC EDGAR filings · CIK 0000939767 · as of 2026-01-02. Facts from filings plus Stocktoria's own computed scores — not investment advice.